4.7 Article

MiR-20a Induces Cell Radioresistance by Activating the PTEN/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma

Journal

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ijrobp.2015.04.007

Keywords

-

Funding

  1. National Natural Scientific Foundation of China [81272507]
  2. Natural Science Foundation of Guangdong Province [S2013010014185]
  3. Pearl River Nova Program of Guangzhou, Guangdong Province [2014J2200015]

Ask authors/readers for more resources

Purpose: To investigate the role of miR-20a in hepatocellular carcinoma (HCC) cell radioresistance, which may reveal potential strategies to improve treatment. Methods and Materials: The expression of miR-20a and PTEN were detected in HCC cell lines and paired primary tissues by quantitative real-time polymerase chain reaction. Cell radiation combined with colony formation assays was administrated to discover the effect of miR-20a on radiosensitivity. Bioinformatics prediction and luciferase assay were used to identify the target of miR-20a. The phosphatidylinositol 3-kinase inhibitor LY294002 was used to inhibit phosphorylation of Akt, to verify whether miR-20a affects HCC cell radioresistance through activating the PTEN/PI3K/Akt pathway. Results: MiR-20a levels were increased in HCC cell lines and tissues, whereas PTEN was inversely correlated with it. Overexpression of miR-20a in Bel-7402 and SMMC-7721 cells enhances their resistance to the effect of ionizing radiation, and the inhibition of miR-20a in HCCLM3 and QGY-7701 cells sensitizes them to it. PTEN was identified as a direct functional target of miR-20a for the induction of radioresistance. Overexpression of miR-20a activated the PTEN/PI3K/Akt signaling pathway. Additionally, the kinase inhibitor LY294002 could reverse the effect of miR-20a-induced radioresistance. Conclusion: MiR-20a induces HCC cell radioresistance by activating the PTEN/PI3K/Akt pathway, which suggests that miR-20a/PTEN/PI3K/Akt might represent a target of investigation for developing effective therapeutic strategies against HCC. (C) 2015 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

MET Copy Number Gain Is Associated with Gefitinib Resistance in Leptomeningeal Carcinomatosis of EGFR-mutant Lung Cancer

Shigeki Nanjo, Sachiko Arai, Wei Wang, Shinji Takeuchi, Tadaaki Yamada, Akito Hata, Nobuyuki Katakami, Yasunori Okada, Seiji Yano

MOLECULAR CANCER THERAPEUTICS (2017)

Article Oncology

Zinc finger protein 307 functions as a tumor-suppressor and inhibits cell proliferation by inducing apoptosis in hepatocellular carcinoma

Yonghao Liang, Qisheng Li, Keli Chen, Wen Ni, Zetao Zhan, Feng Ye, Yiyi Li, Yuan Fang, Fengjiao Zhang, Longhua Chen, Yi Ding

ONCOLOGY REPORTS (2017)

Article Oncology

Histone Methyltransferase SETDB1 Promotes the Progression of Colorectal Cancer by Inhibiting the Expression of TP53

Keli Chen, Fengjiao Zhang, Jie Ding, Yonghao Liang, Zetao Zhan, Yizhi Zhan, Long-hua Chen, Yi Ding

JOURNAL OF CANCER (2017)

Article Oncology

Histone methyltransferase SETDB1 promotes cells proliferation and migration by interacting withTiam1 in hepatocellular carcinoma

Yuqin Zhang, Jing Huang, Qisheng Li, Keli Chen, Yonghao Liang, Zetao Zhan, Feng Ye, Wen Ni, Longhua Chen, Yi Ding

BMC CANCER (2018)

Article Oncology

Inhibition of NF-κB improves sensitivity to irradiation and EGFR-TKIs and decreases irradiation-induced lung toxicity

Rong Wang, Shunli Peng, Xiaojuan Zhang, Zhenming Wu, Hezhen Duan, Yawei Yuan, Wei Wang

INTERNATIONAL JOURNAL OF CANCER (2019)

Article Oncology

Histone methyltransferase SETDB1 promotes colorectal cancer proliferation through the STAT1-CCND1/CDK6 axis

Lu Yu, Feng Ye, Yi-Yi Li, Yi-Zhi Zhan, Yang Liu, Hong-Mei Yan, Yuan Fang, Yu-Wen Xie, Feng-Jiao Zhang, Long-Hua Chen, Yi Ding, Ke-Li Chen

CARCINOGENESIS (2020)

Article Biochemistry & Molecular Biology

EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expression

Shunli Peng, Rong Wang, Xiaojuan Zhang, Yueyun Ma, Longhui Zhong, Ke Li, Akihiro Nishiyama, Sachiko Arai, Seiji Yano, Wei Wang

MOLECULAR CANCER (2019)

Article Oncology

Dual inhibition of VEGF and PARP suppresses KRAS-mutant colorectal cancer

Longhui Zhong, Rong Wang, Yanxia Wang, Shunli Peng, Yueyun Ma, Sijie Ding, Hong Yang, Shiyu Chen, Xiaoqing Luo, Wei Wang

NEOPLASIA (2020)

Review Medicine, Research & Experimental

Targeted therapies for RET-fusion cancer: Dilemmas and breakthrough

SiJie Ding, Rong Wang, ShunLi Peng, Xiaoqing Luo, LongHui Zhong, Hong Yang, YueYun Ma, ShiYu Chen, Wei Wang

BIOMEDICINE & PHARMACOTHERAPY (2020)

Article Oncology

Prognostic values, ceRNA network, and immune regulation function of SDPR in KRAS-mutant lung cancer

Xiaoqing Luo, Shunli Peng, Sijie Ding, Qin Zeng, Rong Wang, Yueyun Ma, ShiYu Chen, Yanxia Wang, Wei Wang

Summary: The study demonstrates that SDPR expression is downregulated in lung cancer, and low expression is associated with shorter overall survival in patients. It may also be related to immune system suppression.

CANCER CELL INTERNATIONAL (2021)

Article Oncology

Characteristics and response to next-generation sequencing-guided therapy in locally advanced or metastatic esophageal cancer

Yueyun Ma, Wenjie Li, Shiyu Chen, Shuimiao Lin, Sijie Ding, Xiaomei Zhou, Tongxin Liu, Rong Wang, Wei Wang

Summary: In this study, a comprehensive analysis was performed on patients with advanced or metastatic esophageal cancer who underwent next-generation sequencing (NGS). Mutations in 227 genes were identified, with TP53, NQO1, DPYD, GSTM1, XRCC1 and ERCC1 being the most common. Patients who received NGS-guided therapy showed improved clinical outcomes. The study highlights the importance of NGS in precision therapy for esophageal cancer.

INTERNATIONAL JOURNAL OF CANCER (2023)

Article Dermatology

Insights into risk factors for basal cell carcinoma: a Mendelian randomization study

Wenjie Li, Wei Wang

Summary: This study conducted a Mendelian randomization analysis and found that telomere length, birthweight, and height may be associated with an increased risk of basal cell carcinoma (BCC). This finding can help identify high-risk populations susceptible to BCC.

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2023)

Article Oncology

Decoding the genetic links between serum lipidomic profile, amino acid biomarkers, and programmed cell death protein-1/programmed cell death-ligand-1

Wenjie Li, Wei Wang

Summary: Through large-scale genome-wide association studies, the associations between lipid metabolism, amino acids, and PD-1/PD-L1 were revealed. The study identified a negative association between alanine and PD-1 expression, and fourteen specific lipid metabolism biomarkers significantly linked to PD-L1 expression, including cholesterol and triglycerides. Glutamine and phenylalanine were also found to have a causal association with the expression of PD-L1. The findings suggest that targeting lipid and amino acid metabolisms may improve the efficacy of immunotherapy.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2023)

Article Oncology

Unraveling the genetic associations between PD-1/PD-L1 and 13 circulating biomarkers linked to physiological and pathological processes

Wenjie Li, Wei Wang

Summary: This study reveals the genetic interconnectedness between PD-1/PD-L1 and circulating proteins, providing insights into the underlying mechanisms and potential implications in cancer immunotherapy.

CLINICAL & TRANSLATIONAL ONCOLOGY (2023)

Article Oncology

A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1

Wen Ni, Yuqin Zhang, Zetao Zhan, Feng Ye, Yonghao Liang, Jing Huang, Keli Chen, Longhua Chen, Yi Ding

JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)

No Data Available